Sort Results:
List of Materials
Case Study: The Discovery of Telaprevir (VX-950, Incivek) for the treatment of Hepatitis CThis Case study shows the drug discovery process of Telaprevir for Hepatitis. IT discusses the background of Hepatitis, and the basic information on Hepatitis C, Preclinical studies, Clinical studies, critical findings, timeline to approval and the... |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Dana Ferraris, Ph.D., M.B.A. |
|
![]() |
CNS Medicinal Chemistry: Introduction and a Case Study – GlyT1This lecture will provide an overview of the drug discovery process with specific attention being paid to the role of medicinal chemistry, and key issues for the CNS disease-focused medicinal chemist (Lipinski’s rules, CNS penetration, transporter... |
Vanderbilt Specialized Chemistry Center (MLPCN) Vanderbilt University Presenter: Craig W. Lindsley |
![]() |
Drug-Like Properties and Druggable TargetsA lecture discussing the concept of drug-like molecular properties, druggable targets, and chemical space. |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Takashi Tsukamoto, Ph.D. |
![]() |
Formulation and Route of AdministrationIn order to exert the desired effect in a proof-of-concept animal study, a drug molecule or development candidate first of all needs to be bioavailable and lack of solubility therefore often poses the first barrier to successful translation a... |
Department of Pharmacology UC Davis Presenter: Heike Wulff, Ph.D. |
![]() |
Hit to Lead to CandidateOnce a drug target has been identified and assays developed, hits (compounds with confirmed activity at the target) are obtained from many sources - often from high-throughput screening. Drug discovery scientists investigate the hits by obtaining or... |
Johns Hopkins School of Medicine Presenter: Jim Barrow, Ph.D. |
![]() |
In Vitro Pharmacology IA lecture discussing the general background of In Vitro Pharmacology and the two different target-based assays: enzymatic and Receptor. |
BSi NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Camilo Rojas, Ph.D. |
![]() |
In Vitro Pharmacology IIA lecture discussing Phenotype-Based Assays, High Throughput Screening, and Weeding out undesirable hits in In Vitro Pharmacology. |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Camilo Rojas, Ph.D. |
![]() |
Lead OptimizationA lecture on hit to lead and lead optimization. This is the tenth lecture in a 15-week course, Introduction to Drug Discovery Research, given at Johns Hopkins University School of Medicine, discussing the various aspects of the drug discovery... |
Brain Science Institute NeuroTranslational Drug Discovery Program Johns Hopkins University Presenter: Takashi Tsukamoto, Ph.D. |
![]() |
The Small Molecule Discovery CenterThis presentation introduces the Small Molecule Discovery Center at UCSF, and describes the center’s goals, philosophy, and examples of projects. Several different approaches to interacting with pharmaceutical companies are also summarized. |
Small Molecule Discovery Center University of California San Francisco Presenter: Michelle Arkin |

